Delivery Order 36C24823D0050-36C24824N0063
- Not listed
- This is a federal contract award to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business that specializes in manufacturing and supplying radiopharmaceuticals and nuclear medicine products. The contract, valued at $122,387.32, is a delivery order awarded by the U.S. Department of Veterans Affairs (VA) for the provision of radiopharmaceuticals such as Ga-68 Dotatate, iodine I-123, technetium-99m, and other specialized medical...
- This federal contract award, valued at $184,507.80, was issued by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The contract is for the delivery of radiopharmaceuticals, which are specialized medical isotopes and imaging agents used in nuclear medicine procedures to support diagnostic imaging and cancer treatment services for veterans. Jubilant Radiopharma is a for-profit, self-certified small disadvantaged...
- This contract award is for the supply of nuclear medicine radiopharmaceuticals to the Department of Veterans Affairs (VA). The prime contractor is Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. This award has a ceiling value of $73,037 and is a firm-fixed-price delivery order contract. Jubilant Radiopharma provides a variety of essential medical isotopes and radiopharmaceuticals used in diagnostic imaging and cancer...
- This is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for the delivery of radiopharmaceutical products. The $230,497.52 contract supports nuclear medicine procedures, diagnostic imaging, and cancer treatment across the VA's nationwide network of medical facilities. Jubilant Radiopharma, a for-profit small disadvantaged business, has been awarded numerous...
- This federal contract award is for RADIOPHARMACEUTICALS, awarded to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma. The contract, valued at $929,720.00, was awarded on October 1, 2024 by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 8 (VISN 8). Jubilant Radiopharma is a key supplier of radiopharmaceuticals and nuclear medicine products to the VA, supporting its healthcare services for veterans across the country....
- The U.S. Department of Veterans Affairs (VA) awarded a firm-fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a self-certified small disadvantaged business. The $39,692.91 contract provides specialized radiopharmaceutical products, including Ga-68 Dotatate, iodine I-123, and technetium-99m, to support nuclear medicine diagnostic imaging and treatment procedures for veterans and military personnel across the VA's nationwide...
- This federal contract award is for the procurement of RADIOPHARMACEUTICALS by the Department of Veterans Affairs (VA) through VA's Network Contracting Office 20. The contract was awarded to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a small disadvantaged business. The firm-fixed-price contract has a ceiling value of $111,944.77 and a period of performance through June 30, 2024. Jubilant Radiopharma is a key supplier of radiopharmaceuticals and nuclear...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $93,446.62 firm fixed-price delivery order contract to Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), a self-certified small disadvantaged business. This contract is to provide radiopharmaceuticals supporting nuclear medicine services and procedures for veterans at VA medical facilities. Jubilant Radiopharma has held multiple indefinite delivery contracts and blanket purchase...
- This federal contract award, valued at $83,454.67, was issued by the Department of Veterans Affairs (VA) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a self-certified small disadvantaged business. The contract is for the delivery of radiopharmaceuticals, which are specialized nuclear medicine products used in diagnostic imaging and treatment procedures for veterans and military personnel. The contract is a delivery order under a larger Indefinite...
- This is a federal contract award to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business that specializes in manufacturing and supplying radiopharmaceuticals and nuclear medicine products. The contract, valued at $580,459.86, is a firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) for the procurement of radiopharmaceuticals for the Lebanon VA Medical Center. The contract is not...
- 36C24823D0050Indefinite Delivery Contract
- 36C24823D0050-36C24824N0063Delivery Order
This federal contract award is for the delivery of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The prime contractor, Jubilant Draximage Radiopharmacies, Inc. (doing business as Jubilant Radiopharma), is a for-profit, self-certified small disadvantaged business that specializes in manufacturing and distributing nuclear medicine products. The contract is a firm-fixed-price delivery order with a ceiling value of $358,580.57 and a period of performance ending on September 30, 2024. Jubilant Radiopharma will provide a variety of radiopharmaceuticals, such as Ga-68 Dotatate, iodine I-123, and technetium-99m, to support nuclear medicine procedures, diagnostic imaging, and cancer treatment at VA medical facilities. The contract is not set aside and is funded by the VA, which operates the Veterans Integrated Service Network 8 (VISN 8) to provide healthcare services to veterans. Jubilant Radiopharma holds multiple Indefinite Delivery Vehicles (IDVs) with the VA, including Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with potential values ranging from $420,000 to $39.8 million. These IDVs allow the VA to efficiently procure radiopharmaceuticals and related services across its nationwide network of medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($411k) | 9/17/25 | |
| P00001 | Supplemental Agreement for work within scope | $10.0k | 8/30/24 | |
| Not listed | Not listed | $759.3k | 10/1/23 |